SGLT-2is Edge GLP-1 RAs on Foot Disease - Poll - MDSpire

SGLT-2is Edge GLP-1 RAs on Foot Disease

Danish target trial emulation finds modest neuropathy benefit emerging following year 3, but high discontinuation rates complicate causal interpretation

  • By

  • Kerri Miller

  • January 5, 2026

  • 5 min

Share

Original Source(s)

SGLT-2is Edge GLP-1 RAs on Foot Disease

  • by Kerri Miller

  • January 5, 2026

Related Content

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Waist-to-height ratio for OSA risk: a comparative analysis of NHANES and a clinical data

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.